By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Helicos BioSciences' revenues for the second quarter rose 78 percent as grant revenues increased by 170 percent, the company disclosed in a document filed with the US Securities and Exchange Commission after the close of the market on Monday.

For the three months ended June 30, total revenues bounced to $661,000 from $371,000 a year ago. While product revenue dropped to $85,000 from $158,000 in Q2 2009, grant revenues shot up to $576,000 from $213,000 year over year.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.

Sponsored by
Thermo Fisher Scientific

In this webinar, the first in the “New Frontiers in Liquid Biopsy Research” series, Bea Bellosillo, head of pathology at the Hospital del Mar, will discuss her experience evaluating an early-access lung cancer panel that detects copy number variants and fusions.